Medical information Clinical review pending

Infection Testing

Bacterial Meningitis Screen Test

The Bacterial Meningitis Screen Test helps diagnose bacterial meningitis, a serious infection of the membranes surrounding the brain and spinal cord. It detects specific bacteria like Group B Streptococcus and Neisseria meningitidis. Essential for patients with meningitis symptoms or risk factors.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Serum (2 mL minimum), Cerebrospinal Fluid (CSF) (2 mL minimum), or Random Urine (5 mL minimum). Samples must be collected in appropriate sterile containers.
Results: Confirm with the laboratory before booking.
Preparation: No special preparation is required for the patient before the test.

Test priceKSh 8,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Bacterial Meningitis Screen Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Symptoms suggestive of meningitis (fever, headache, stiff neck)
✓History of close contact with a meningitis case
✓Individuals with weakened immune systems
✓Patients with chronic health conditions
✓Monitoring in outbreak situations
✓Diagnostic workup for neurological symptoms

In plain language

What this test helps you understand

This test aids in the early diagnosis of bacterial meningitis, allowing for prompt treatment and potentially preventing severe complications. It helps identify the specific bacterial cause, guiding appropriate antibiotic therapy.

The Bacterial Meningitis Screen Test is a vital diagnostic tool used to identify bacterial infections affecting the meninges, the protective membranes surrounding the brain and spinal cord. Early detection is crucial because bacterial meningitis can lead to severe complications, including brain damage, hearing loss, or even death. This test is particularly important for individuals presenting symptoms suggestive of meningitis, such as fever, severe headache, stiff neck, and altered mental status.

This test detects the presence of specific bacteria known to cause meningitis, including Group B Streptococcus, H.influenzae Type B, Streptococcus pneumoniae, Neisseria meningitidis (Groups A, C, Y, W135 & B), and E.coli K1.

Individuals who should consider the Bacterial Meningitis Screen Test include those showing symptoms of meningitis, individuals with a history of close contact with someone diagnosed with bacterial meningitis, and those with compromised immune systems or chronic health conditions.

Taking this test offers several benefits, including early diagnosis leading to timely treatment, aiding physicians and neurologists in making informed decisions, and reducing the risk of severe complications associated with delayed treatment.

Results help determine the presence of bacterial infection. A positive result indicates the need for immediate medical intervention. Discuss your results with your healthcare provider for a comprehensive understanding and further steps.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo special preparation is required for the patient before the test.

SampleSerum (2 mL minimum), Cerebrospinal Fluid (CSF) (2 mL minimum), or Random Urine (5 mL minimum). Samples must be collected in appropriate sterile containers.

MethodologyMolecular methods (e.g., PCR) are typically used to detect bacterial DNA in the provided sample.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects specific bacterial pathogens. It may not detect all possible causes of meningitis, including viral or fungal types. False negatives or positives can occur, though rare. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

Bacterial meningitis is a serious infection of the meninges, the membranes surrounding the brain and spinal cord, caused by bacteria.

Early diagnosis allows for prompt treatment with antibiotics, which is crucial to prevent severe complications like brain damage or death.

Common symptoms include sudden high fever, severe headache, stiff neck, nausea or vomiting, confusion, and sensitivity to light.

The test can be performed on serum, cerebrospinal fluid (CSF), or urine samples. Your doctor will advise on the appropriate sample.

Turnaround time varies. Please confirm the specific timeframe with the laboratory before booking.

Insurance coverage varies. Please check with your insurance provider regarding coverage for this specific test.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp